It is unclear whether the difference is due to the stronger association between insulin resistance and AD in patients without as compared to those with the risk allele or whether insulin administration aggravates impairments in brain glucose metabolism in carriers of the APOE4+ genotype [39]. The gene discussed is INS; the disease is Alzheimer disease.